171 related articles for article (PubMed ID: 11027412)
1. Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor.
Malm J; Hellman J; Hogg P; Lilja H
Prostate; 2000 Oct; 45(2):132-9. PubMed ID: 11027412
[TBL] [Abstract][Full Text] [Related]
2. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
Robert M; Gibbs BF; Jacobson E; Gagnon C
Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
[TBL] [Abstract][Full Text] [Related]
3. Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen.
Denmeade SR; Lou W; Lövgren J; Malm J; Lilja H; Isaacs JT
Cancer Res; 1997 Nov; 57(21):4924-30. PubMed ID: 9354459
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.
Lövgren J; Airas K; Lilja H
Eur J Biochem; 1999 Jun; 262(3):781-9. PubMed ID: 10411640
[TBL] [Abstract][Full Text] [Related]
5. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen.
Jonsson M; Linse S; Frohm B; Lundwall A; Malm J
Biochem J; 2005 Apr; 387(Pt 2):447-53. PubMed ID: 15563730
[TBL] [Abstract][Full Text] [Related]
6. Characterization of semenogelin II and its molecular interaction with prostate-specific antigen and protein C inhibitor.
Kise H; Nishioka J; Kawamura J; Suzuki K
Eur J Biochem; 1996 May; 238(1):88-96. PubMed ID: 8665956
[TBL] [Abstract][Full Text] [Related]
7. Design of new and sensitive fluorogenic substrates for human kallikrein hK3 (prostate-specific antigen) derived from semenogelin sequences.
Réhault S; Brillard-Bourdet M; Bourgeois L; Frenette G; Juliano L; Gauthier F; Moreau T
Biochim Biophys Acta; 2002 Apr; 1596(1):55-62. PubMed ID: 11983421
[TBL] [Abstract][Full Text] [Related]
8. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation.
Deperthes D; Frenette G; Brillard-Bourdet M; Bourgeois L; Gauthier F; Tremblay RR; Dubé JY
J Androl; 1996; 17(6):659-65. PubMed ID: 9016396
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin.
Robert M; Gagnon C
Biol Reprod; 1996 Oct; 55(4):813-21. PubMed ID: 8879494
[TBL] [Abstract][Full Text] [Related]
10. The interaction among protein C inhibitor, prostate-specific antigen, and the semenogelin system.
Suzuki K; Kise H; Nishioka J; Hayashi T
Semin Thromb Hemost; 2007 Feb; 33(1):46-52. PubMed ID: 17253189
[TBL] [Abstract][Full Text] [Related]
11. Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase.
Peter A; Lilja H; Lundwall A; Malm J
Eur J Biochem; 1998 Mar; 252(2):216-21. PubMed ID: 9523691
[TBL] [Abstract][Full Text] [Related]
12. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein.
Robert M; Gagnon C
Cell Mol Life Sci; 1999 Jun; 55(6-7):944-60. PubMed ID: 10412373
[TBL] [Abstract][Full Text] [Related]
13. Biological activity of prostate-specific antigen isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electroelution.
Tessmer U; Quack T; Donn F; Leuner A; Dernick R
Electrophoresis; 1995 May; 16(5):793-9. PubMed ID: 7588564
[TBL] [Abstract][Full Text] [Related]
14. Ejaculates from the common marmoset (Callithrix jacchus) contain semenogelin and beta-microseminoprotein but not prostate-specific antigen.
Valtonen-André C; Olsson AY; Nayudu PL; Lundwall A
Mol Reprod Dev; 2005 Jun; 71(2):247-55. PubMed ID: 15791587
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.
Christensson A; Laurell CB; Lilja H
Eur J Biochem; 1990 Dec; 194(3):755-63. PubMed ID: 1702714
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II.
Malm J; Hellman J; Magnusson H; Laurell CB; Lilja H
Eur J Biochem; 1996 May; 238(1):48-53. PubMed ID: 8665951
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 is a substrate for prostate specific antigen (PSA) in human seminal plasma.
Saraswati S; Block AS; Davidson MK; Rank RG; Mahadevan M; Diekman AB
Prostate; 2011 Feb; 71(2):197-208. PubMed ID: 20672323
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.
Ménez R; Michel S; Muller BH; Bossus M; Ducancel F; Jolivet-Reynaud C; Stura EA
J Mol Biol; 2008 Feb; 376(4):1021-33. PubMed ID: 18187150
[TBL] [Abstract][Full Text] [Related]
19. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.
Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O
Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755
[TBL] [Abstract][Full Text] [Related]
20. Substrate specificity of prostate-specific antigen (PSA).
Coombs GS; Bergstrom RC; Pellequer JL; Baker SI; Navre M; Smith MM; Tainer JA; Madison EL; Corey DR
Chem Biol; 1998 Sep; 5(9):475-88. PubMed ID: 9751643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
